Results 1 to 10 of about 90,437 (193)
Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases [PDF]
Pharmaceutics, 2020 According to the World Health Organization, corneal diseases are the fourth leading cause of blindness worldwide accounting for 5.1% of all ocular deficiencies. Current therapies for corneal diseases, which include eye drops, oral medications, corrective
Prabhakar Bastola +3 more
doaj +5 more sources
Nanomedicine Approaches for Corneal Diseases [PDF]
Journal of Functional Biomaterials, 2015 Corneal diseases are the third leading cause of blindness globally. Topical nonsteroidal anti-inflammatory drugs (NSAIDs), steroids, antibiotics and tissue transplantation are currently used to treat corneal pathological conditions. However, barrier properties of the ocular surface necessitate high concentration of the drugs applied in the eye ...
Shyam S Chaurasia +2 more
exaly +5 more sources
Methylation in cornea and corneal diseases: a systematic review [PDF]
Cell Death DiscoveryCorneal diseases are among the primary causes of blindness and vision loss worldwide. However, the pathogenesis of corneal diseases remains elusive, and diagnostic and therapeutic tools are limited.
Yutong Xia +11 more
doaj +3 more sources
The Role of Rho Kinase Inhibitors in Corneal Diseases [PDF]
Drug Design, Development and TherapyStefan Futterknecht,1,2 Eleftherios Chatzimichail,1 Konstantin Gugleta,1,3 Georgios D Panos,4,5,* Zisis Gatzioufas1,3,* 1Department of Ophthalmology, University Hospital of Basel, Basel, Switzerland; 2Institute of Molecular and Clinical ...
Futterknecht S +4 more
doaj +4 more sources
Corneal Disease & Transplantation [PDF]
Journal of Clinical Medicine, 2022 Corneal diseases represent the third leading cause of blindness worldwide, and corneal transplantation, which aims at restoring corneal clarity and vision, is the most frequently performed transplant worldwide [...]
Giulia Coco, Vito Romano
openaire +6 more sources
Artificial intelligence and corneal diseases. [PDF]
Curr Opin Ophthalmol, 2022 Purpose of review Artificial intelligence has advanced rapidly in recent years and has provided powerful tools to aid with the diagnosis, management, and treatment of ophthalmic diseases. This article aims to review the most current clinical artificial intelligence applications in anterior segment diseases, with an emphasis on ...
Kang L, Ballouz D, Woodward MA.
europepmc +3 more sources
Cell Therapy of Corneal Diseases. [PDF]
Cornea, 2016 Mesenchymal stem cells isolated from connective tissues are pluripotent and differentiate into phenotypes of connective tissue cell lineages (osteoblasts, chondrocytes, and adipocytes) in vitro and in vivo. They have been used to treat mouse models of connective tissue disease such as lumican-null (Lum) and mucopolysaccharidosis (Gusb) mice ...
Kao WW, Coulson-Thomas VJ.
europepmc +4 more sources
Mesenchymal Stem Cells and Exosomes: A Novel Therapeutic Approach for Corneal Diseases [PDF]
International Journal of Molecular Sciences, 2023 Se-Heon Oh, Ho Seok Chung, Hun Lee
exaly +2 more sources
Metabolomics in Corneal Diseases: A Narrative Review from Clinical Aspects [PDF]
Metabolites, 2023 Alvin Wei Jun Teo +2 more
exaly +2 more sources
Cells, 2023 (1) Background: Cell injection therapy is an emerging treatment for bullous keratopathy (BK). Anterior segment optical coherence tomography (AS-OCT) imaging allows the high-resolution assessment of the anterior chamber. Our study aimed to investigate the
Evan N. Wong +7 more
doaj +1 more source